Artemisinin-resistant malaria in Asia

New England Journal of Medicine

Volumn 361, Issue 5, 2009, Pages 540-541

  Noedl, Harald ^a   Socheat, Duong ^b   Satimai, Wichai ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; DIHYDROARTEMISININ; MEFLOQUINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; BANGLADESH; BLOOD SAMPLING; CAMBODIA; DRUG TREATMENT FAILURE; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; LETTER; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SOUTH ASIA; SOUTHEAST ASIA; THAILAND; TREATMENT RESPONSE;

EID: 68049146050     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0900231     Document Type: Letter

References (5)

1. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008;359:2619-2620
2. Enserink M. Malaria: signs of drug resistance rattle experts, trigger bold plan. Science 2008;322:1776.
3. Vijaykadga S, Rojanawatsirivej C, Cholpol S, et al. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate- mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 2006;11:211-219
4. Noedl H, Krudsood S, Leowattana W, et al. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother 2007;51:651-656
5. Thriemer K, Haque R, Wagatsuma Y, et al. Therapeutic efficacy of quinine plus sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Bangladesh. Am J Trop Med Hyg 2006;75:645-649 (Pubitemid 46941269)